Stockreport

Akeso Marks Profit Milestone With Swift Rights Issue [Seeking Alpha]

Summit Therapeutics Inc.  (SMMT) 
Last summit therapeutics inc. earnings: 6/12 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: summitplc.com/investors/investor-centre
PDF The next highly anticipated product in the firm's drug pipeline is ivonescimab, the first PD-1/VEGF bispecific antibody to enter Phase III clinical trials. The scale [Read more]